Literature DB >> 10930981

Mobilization of CD34+ haematopoietic stem cells is associated with a functional inactivation of the integrin very late antigen 4.

M Lichterfeld1, S Martin, L Burkly, R Haas, R Kronenwett.   

Abstract

The beta1 integrin very late antigen 4 (VLA-4) plays a central role in mobilization and homing of CD34+ cells. In this study, we examined the activation state of VLA-4 on CD34+ cells from bone marrow (BM) and peripheral blood (PB) by flow cytometry using a vascular cell adhesion molecule I-immunoglobulin (VCAM-I/IgG) fusion protein as soluble ligand. In an intraindividual analysis, we found a significantly reduced affinity and avidity of the VLA-4 receptor on CD34+ cells from PB during granulocyte colony-stimulating factor (G-CSF)-enhanced marrow recovery in comparison with steady-state BM. Moreover, the amount of circulating CD34+ cells during marrow recovery was inversely related to the activation state but not to the expression level of VLA-4, suggesting that a modulation of the functional state of VLA-4 is involved in the mobilization of CD34+ cells. Moreover, VLA-4 function on CD34+ cells from BM was associated with the maturation state of CD34+ cells as high-affinity VLA-4 receptors were observed on the vast majority of more primitive CD34+ cells. In addition, we found that Mg2+ ions as well as co-incubation of CD34+ cells with endothelial cells resulted in an activation of the VLA-4 receptor. In conclusion, modulation of the functional state of VLA-4 appears to be of relevance for the mobilization and homing of CD34+ haematopoietic stem cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930981     DOI: 10.1046/j.1365-2141.2000.02130.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  15 in total

Review 1.  The role of Eph/ephrin molecules in stromal–hematopoietic interactions.

Authors:  Thao M Nguyen; Agnieszka Arthur; Stan Gronthos
Journal:  Int J Hematol       Date:  2016-02       Impact factor: 2.490

2.  Hematopoietic progenitor cells (HPC) from mobilized peripheral blood display enhanced migration and marrow homing compared to steady-state bone marrow HPC.

Authors:  Halvard Bonig; Gregory V Priestley; Vivian Oehler; Thalia Papayannopoulou
Journal:  Exp Hematol       Date:  2007-02       Impact factor: 3.084

Review 3.  Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

Authors:  M P Rettig; G Ansstas; J F DiPersio
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

4.  Treatment effect of low intensity pulsed ultrasound on leukopenia induced by cyclophosphamide in rabbits.

Authors:  Baoru Liu; Yueping Luo; Dong Luo; Weichen Zhou; Yu Zhang; Ruixin He; Junshu Li; Yong Wang; Yan Wang; Wenzhi Chen
Journal:  Am J Transl Res       Date:  2017-07-15       Impact factor: 4.060

5.  Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice.

Authors:  Jeffrey M Bernitz; Michael G Daniel; Yesai S Fstkchyan; Kateri Moore
Journal:  Blood       Date:  2017-02-08       Impact factor: 22.113

Review 6.  Natalizumab and progressive multifocal leukoencephalopathy: what are the causal factors and can it be avoided?

Authors:  Clemens Warnke; Til Menge; Hans-Peter Hartung; Michael K Racke; Petra D Cravens; Jeffrey L Bennett; Elliot M Frohman; Benjamin M Greenberg; Scott S Zamvil; Ralf Gold; Bernhard Hemmer; Bernd C Kieseier; Olaf Stüve
Journal:  Arch Neurol       Date:  2010-08

7.  Constitutively increased neutrophil surface expression of beta2-integrin in Yemenite Jews.

Authors:  Yair Molad; Yuval Konstantino; Konstantine Bloch; Jaqueline Sulkes; Michael A Weingarten
Journal:  Inflammation       Date:  2003-10       Impact factor: 4.092

8.  Functional disruption of alpha4 integrin mobilizes bone marrow-derived endothelial progenitors and augments ischemic neovascularization.

Authors:  Gangjian Qin; Masaaki Ii; Marcy Silver; Andrea Wecker; Evelyn Bord; Hong Ma; Mary Gavin; David A Goukassian; Young-sup Yoon; Thalia Papayannopoulou; Takayuki Asahara; Marianne Kearney; Tina Thorne; Cynthia Curry; Liz Eaton; Lindsay Heyd; Deepika Dinesh; Raj Kishore; Yan Zhu; Douglas W Losordo
Journal:  J Exp Med       Date:  2006-01-09       Impact factor: 14.307

9.  Pharmacodynamic consequences of administration of VLA-4 antagonist CDP323 to multiple sclerosis subjects: a randomized, double-blind phase 1/2 study.

Authors:  Christian Wolf; Jagdev Sidhu; Christian Otoul; Dexter L Morris; Jennifer Cnops; Jorg Taubel; Barbara Bennett
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  The thrombopoietin receptor, c-Mpl, is a selective surface marker for human hematopoietic stem cells.

Authors:  John M Ninos; Leigh C Jefferies; Christopher R Cogle; William G Kerr
Journal:  J Transl Med       Date:  2006-02-16       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.